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		Synopsis



SYNOPSIS
The thesis entitled “Studies Towards the total synthesis of (-)-Hennoxazole A, Passifloricin A, (+)-Cryptocarya Diacetate, and Davanones” has been divided into three chapters.1

Chapter I: 	Towards the total synthesis of (-)-Hennoxazole A.
Section A:     This section deals with the introduction and previous approaches of the (-)-Hennoxazole A.
Section B: 	This section deals with the present work of the (-)-Hennoxazole A.

Chapter II: 	Total synthesis of Passifloricin A and (+)-Cryptocarya Diacetate.
Section A : 	This section describes the introduction, previous approaches and present work of the Passifloricin A.
Section B : 	This section describes the introduction, previous approaches and present   work of the (+)-Cryptocarya Diacetate.

Chapter III: This chapter narrates the introduction, previous approaches and present  
                    work of the (+)-Davanone, (+)-Nordavanone and (+)-Davana Acid.












CHAPTER I: Towards the total synthesis of (-)-Hennoxazole A.
SECTION A: In recent years, marine natural products have attracted considerable attention of synthetic chemists as targets for total synthesis due to their potent biological properties. Hennoxazole A (1) belongs to a group of marine natural products isolated from a marine sponge Polyfibrospongia sp (phylum Porifera) by Scheuer et al.1 in 1991 (Figure 1). This has been found to be highly active, displaying antiviral activity against herpes simplex virus (HSV-1, IC50 = 0.6 µg/mL) and peripheral analgesic activity comparable with that of indomethacin. Hennoxazole A contains a bisoxazole moiety, functionalized tetrahydropyranyl ring and a skipped triene unit. However, the isolation of hennoxazole A, from the marine sponge in low contents prohibits further chemical and biological activities.
 



   
The structural diversity coupled with the high biological activity has intrigued the chemists all over the world in studying the possible synthetic routes for the total synthesis. This section deals with the brief account of the work carried out by the various research groups reported towards the total synthesis of hennoxazole A.
SECTION B: 
	As a part of our program on the synthesis of biologically active marine natural products, it was decided to embark upon the total synthesis of this unique bis-oxazole antiviral molecule Hennoxazole A. Retrosynthetically, hennoxazole A (Scheme 1) was disconnected at C1-C10 fragment 2 and the C11-C25 triene fragment 3. The C1-C10 tetrahydropyran segment could be obtained via Prins cyclization starting from the chirol epoxide 13. The triene fragment 3 was further divided into the oxazole moiety 4 and the diene unit 5. The diene unit 5 in turn could be made starting from (S)-Roche ester 7 via a cyclic lactone intermediate 6.













      



Retrosynthesis:                                Scheme 1
The synthesis of the diene unit 5 was started from (S)-Roche ester 7. Protection of methyl (S)-3-hydroxy-2-methyl propionate 7 as its PMB ether gave 14 in 95% yield (Scheme 2). Reduction of the methyl ester with Dibal-H gave the corresponding aldehyde, which without further purification used for the next step. At this stage, we wanted to establish the cis olefin geometry in a new way. Hence, we decided to make use of stabilized lactone phosporane A, which can give the requisite diastereoselectivity. Thus, Wittig coupling of the above aldehyde with the known phosphorane A5 in refluxing CH2Cl2 gave lactone intermediate 6 in quantitative yield. Complete reduction of the lactone using Dibal-H gave diol 15 in 90% yield. These two primary hydroxyl groups were differentiated by selective chlorination of the allylic alcohol 15 by reaction with the Corey-Kim reagent (NCS/Me2S)6 to result allylic chloride 16, which was reduced with LAH at 0 oC to afford the tri substituted (Z)-olefin 17. The primary hydroxyl group of 17 was oxidized using IBX in DMSO/CH2Cl2 and the resulting aldehyde was subjected to a one-carbon Wittig ylide to afford the non-conjugated diene 5 in 75% yield over two steps. 













Scheme 2. Reagents and conditions: a) (p-methoxy) benzyl 2,2,2-tri chloro acetamidate, TSOH, CH2Cl2, 0 oC, 95%; b) Dibal-H, CH2Cl2, -78 oC, 92%; c) A, CH2Cl2, reflux, 85%, (over 2 steps); d) Dibal H, CH2Cl2, -15 oC, 90%; e) NCS, Me2S, CH2Cl2, 0 oC, 86%; f) LAH, THF, 0 oC, 96%; g) i. IBX, DMSO, CH2Cl2, 0 oC, ii. Ph3PCH3Br, THF, n-BuLi, -78 oC, 75% (Over 2 steps).

The synthesis of the oxazole unit 4 was started by coupling of 4-hexene-1-carboxylic acid 8 with commercially available (±)-serine methyl ester hydrochloride 18 using EDCI, HOBT in the presence of Hunig’s base in CH2Cl2 to give β-hydroxy amide 19 in 92% yield (Scheme 3). Dehydrative cyclization of amide7 with the DAST gave an intermediate oxazoline which was oxidized to the oxazole with BrCCl3 in the presence of DBU to provide 4 in 80% yield.






Scheme 3. Reagents and conditions: a) HOBT, EDCI, Hunig’s base, CH2Cl2, 0 oC, 92%; b) DAST, BrCCl3, DBU, CH2Cl2, -78 to 0 oC, 80%.  

With both coupling partners 4 and 5 in hand, the stage was set for the Grubbs’ cross-metathesis (CM)8 reaction. Unfortunately, attempting cross-metathesis reaction between oxazole unit 4 (containing the terminal olefin) and the non-conjugated diene compound 5 using 5 mol% Grubbs’ second generation catalyst in CH2Cl2 at reflux temperature gave low yields (10-15%) of the coupled product 20 along with the homodimerized product of oxazole unit (Scheme 4).







Scheme 4.
Increased amount of catalyst (up to 20%) and prolonged reaction time at various temperatures did not improve the yield of coupled product. Hence, we planned to study the effect of protecting group. A trial reaction also completely failed to get the required coupled product between protection free diene 21, which was prepared from the diene 5 by exposing to DDQ in aqueous DCM, and oxazole unit 4, instead formation of homodimerised product of oxazole unit was observed (Scheme 5). 







Scheme 5.

Therefore, we decided to mask the free alcohol in compound 21 as silyl ether. Thus, alcohol 21 was treated with TBDMSCl and imidazole in DCM to furnish TBDMS ether 22 in quantitative yield (Scheme 6). Now the Grubbs’ CM reaction was performed between TBDMS protected diene 22 and alkene 4 using 5 mol% catalyst in refluxing DCM for 10 h. Gratifyingly, the reaction proceeded smoothly to furnish the desired coupled product 23 in 84% yield. The silyl deprotection with TBAF followed by oxidation of the resulting alcohol 24 using SO3-Py in DMSO/CH2Cl2 at 0 oC furnished the crude aldehyde. The aldehyde was subjected to Julia-Kocien’ski olefination with 5-(ethylsulfonyl)-1-phenyl-1H-tetrazole B9 using potassium hexamethyldisilazide (KHMDS) as base in 1,2-dimethoxyethane (DME) at -78 oC to give alkene 25 in 72% yield with good stereoselectivity (E:Z = 93:7). Saponification of THF/H2O completed

















Scheme 6. Reagents and conditions: a) TBDMSCl, imidazole, CH2Cl2, 0 oC;  b) Grubbs’ 2nd generation catalyst, CH2Cl2, Reflux, 84%; c) TBAF, THF, 0 oC, 91%; d) i. So3-Py, Et3N, DMSO, CH2Cl2, 0 oC, ii. B, KHMDS, DME, -78 oC, 72% (over 2 steps); e) LiOH, THF, H2O, 0 oC, 94%.

the construction of the C11-C25 triene oxazole fragment 3. The spectral and analytical data of 3 matches with the reported data. 2b
The synthesis of the C1-C10 tetrahydropyran segment 2 commenced from racemic glycidyl ether 26 (Scheme 7) which on Jacobsen resolution using (R,R)-(salen)Co(II) precatalyst,7 AcOH and H2O (0.51 equiv) for 22 hours at room temporature resulted in enantiomerically pure (S)-benzyl glysidyl ether 13. Thus, regioselective opening of epoxide 13 with vinylmagnesium bromide in the presence of CuCN gave benzyl protected homoallylic alcohol 27. Compound 27 on treatment with lithium in liquid NH3 underwent debenzylation to produce diol 28.



Scheme 7. Reagents and conditions: a) (R,R) Co-(salen), AcOH, H2O, THF, 0 oC,22h, 45%; b) VinylMgBr, CuCN, -78 oC-40 oC, 4h, 92%; c) Li, Liq.NH3, THF, -30 oC, 20 min, 75%.    

On the other hand, aldehyde 31 was prepared from propane diol 29 (Scheme 8). Careful protection of propane diol 29 by using benzyl bromide and sodium hydride in dry DMF afforded the monoprotected alcohol 30 in 80% yield (Scheme 8). The compound 30 was oxidized to aldehyde 31 using PCC in CH2Cl2 at 0 oC temperature.





Scheme 8. Reagents and conditions: a) NaH, BnBr, DMF, 80%;b) PPC, CH2Cl2, 0 oC,88%. 

At this juncture, the stage was set for crucial Prins cyclisation reaction (Scheme 9). Subjection of homoallylic alcohol 28 and three equivalents of 3-(benzyloxy)propanal 31 to Prins cyclisation in the presence of TFA in CH2Cl2 resulted in trifluoroacetate 28a. Constant persuasion of thin layer chromatography showed the complete consumption of homoallylic alcohol 28 after 3 hours. After work up, the crude trifluoroacetate 28a on hydrolysis with K2CO3 in MeOH yielded the desired trisubstituted pyran 12 (Scheme 9).




Scheme 9. Reagents and conditions: a) 31, TFA, CH2Cl2, 0 oC; b) K2CO3, MeOH, rt, 0.5 h, 52% (over 2 steps).    

The primary hydroxyl group in compound 12 was selectively tosylated to give primary tosylate 32, which was further converted into iodide 33 by treating with NaI in refluxing acetone (Scheme 10). The compound 33 on reductive ring opening with Zn in ethanol gave 1,3-anti diol 34 in 93% yield. The 1,3-diol compound 34 was protected as an acetonide to give 11 and the terminal olefin was converted into the methyl ketone 35 by Wacker oxidation.11
Attempts to prepare tetrahydropyran 36 in one-pot from 35 under various acidic conditions using PPTS, 4N HCl, FeCl3, CSA, CeCl37H2O, NH4Cl in MeOH resulted in low yields. However, tetardropyran 36 was prepared in high yield by a two step procedure. Thus, the acetonide group of 35 was hydrolysed on treatment with CeCl3.7H2O in CH3CN/H2O and the resulting diol was used without further purification to proceed intramolecular ketalization by PPTs in MeOH to produce tetrahydropyran 36 in 82% yield.









Scheme 10. reagents and conditions: a) Et3N, TsCl, CH2Cl2, 0 oC-rt, 3 h, 95%; b) NaI, Acetone, reflux, 24 h, 94%, c) Unactivated Zn, EtOH, reflux, 1h, 93%; d) 2,2-DMP, PTSA, DMSO, 2 h, 98%, e) PdCl2, Cu(OAc)2. H2O, O2, DMF:H2O (7:1) rt, 20 h, 77%; f) i. CeCl37H2O, CH3CN-H2O, rt, 2 h; ii. MeOH, PPTs, 0.5 h, 82%.

Protection of the secondary alcohol 36 using TIPSOTf and 2,6-lutidine led to the formation of TIPS ether 10, followed by removal of benzyl group provided primary alcohol 37. The alcohol was oxidized and subjected to the chain elongation using two-carbon stable ylide to afford the α,β-unsaturated ester 38.











Scheme 11. Reagents and conditions:  a) TIPSOTf, 2,6-Lutidine, 92%; b) Li, liq.NH3, THF, 80%; c) i. TPAP, NMO, DMSO, rt., ii.  PPh3CHCO2Et, C6H6, 81%; d) AD mix β , tBuOH, H2O, 0 oC, 48h, 88%; e) TEA, TsCl, CH2Cl2, 0 oC- rt, 3h, 77%; f) TBAA, THF-DMF, Reflux, 86%; g) Ag2O, MeI, CH3CN, 0 oC, 68%. 

Sharpless asymmetric dihydroxylation of 38 with Admix-β afforded diol 39 (Scheme 11). Regioselective monotosylation12 of diol 39 at the α–position to the ester with p-TsCl resulted in the tosylate 40 in 77% yield. The displacement of tosyl group with n-Bu4NN3 in THF/DMF provided the azide 9 in 86% yield. O-Methylation13 of secondary hydroxyl group in 9 using MeI in the presence of Ag2O in CH3CN afforded 41 in 68% yield. Reduction of the azide and ester group completes the formation of the required C1-C10 tetrahydropyran segment 2. Unfortunately, all attempts to reduce two functional groups with various reducing agents such as LAH, Dibal-H, BH3.DMS failed to give the required product, instead decomposition of the starting material was observed.
In summary, we have developed a convergent strategy for the synthesis of C1-C10 and C11-C25 segments of hennoxazole A. Prins cyclization, cross metathesis and Julia olefinataion reactions are used as key steps along with the utilization of lactone phosphorane in generation of non-conjugated diene.  

CHAPTER II: Total synthesis of passifloricin A.
SECTION A: Passifloricin A 42, a 6-substituted α,β-unsubstituted δ-lactone (Figure 1) was isolated from Passiflora foetida,1 a species from the family Passifloraceae which grows in tropical zones of America. It was found to show very interesting Leishmanicidal2 and antiprotozoal3 activities. The relative configuration of passifloricin A has been established based on purely spectroscopic findings and the structure was proposed to be 42a. Several syntheses4 of proposed structure of Passifloricin A 42a were reported and however it was realized that the NMR data of synthetic products did not match with the data of natural product and they were different. The quantum mechanical 13C NMR GIAO chemical shift calculations5 as well as fluorous tagging en route6 also proved that the proposed structure is incorrect. The proposed structure of 42a was revised to be 42 by synthesizing several isomers7 of natural product and studying their spectral data. 











In our retrosynthetic analysis (Scheme 12), we envisaged that the target molecule 42 could be prepared through ring-closing metathesis of compound 43 which in turn could be made by a cross-metathesis reaction of two chiral allylic alcohol derivatives I and II. 












Scheme 12. Retrosynthetic analysis for passifloricin A 42


Compound I in turn could be obtained from tetrahydropyranol 44, prepared by a Prins cyclisation reaction whereas the chiral allylic acetate II could be obtained from readily available aldehyde 45.
The synthesis of the fragment I (Scheme 13) began with the Prins cyclisation reaction of chiral homoallyl alcohol 46 with 3-benzyloxypropanal in the presence of triflouroacetic acid followed by hydrolysis of the resulting trifluoroacetate to afford the tetrahydropyranol 44. The primary hydroxyl group in compound 44 was selectively protected as TBS ether 47, and the secondary hydroxyl group was inverted under standard Mitsunobu conditions12 to afford 48, which was expected to give the required syn 1,3–diol system after elaboring. Protection of the secondary alcohol in compound 48 as the methoxymethyl ether 49 followed by removal of silyl group provided primary alcohol 50 in good yield. Treatment of alcohol with I2 in the presence of TPP and imidazole in CH3CN-Et2O gave the corresponding iodo compound 51. Elimination of HI13 from 51, using sodium hydride in DMF, provided enolic exocyclic alkene 52, which on column chromatography using silica gel gave rearranged product 53. 













Scheme 13.  Reagents and conditions: a) i) 3-benzyloxypropanal, TFA, CH2Cl2, 3 h; ii) K2CO3, MeOH, rt, 0.5 h, 56% (over 2 steps); b) i. TBDMS-Cl, imidazole, dry CH2Cl2, 2 h, 92%; c) p​-NO2CH2COOH, DEAD, Ph3P, Toluene, 0 oC-rt, 30 min, then K2CO3, MeOH, rt, 4 h, 75%; d) MOM-Cl, Hunig’s base, 0 oC, 92%; e) TBAF, dry THF, rt, 8h, 93%; f) Ph3P, imidazole, iodine, CH3CN-Et2O, 0 oC, 2 h, 88%; g) i. NaH, DMF,  r.t., 6 h; ii. silica gel rearrangement, 80%; (h) i. O3, Ph3P, CH3CN-Et2O, ii. Ph3P=CH2, n-BuLi, THF, –78 to 0 °C, 71%; (i) i. K2CO3, MeOH, r.t., 2 h, 95%; j) TFA–CH2Cl2 (1:4), 25 °C, 2 h, 88%; k) 2,2-DMP, PPTS, CH2Cl2 , 2 h, 95%.

Compound 53 was subjected to ozonolysis to give the corresponding acetoxy aldehyde, which without purification was treated with a methylene triphenyl phosphorane to furnish alkene 54.14 Hydrolysis of the acetate and removal of MOM group resulted in a diol 56, which was protected as the acetonide, using dimethoxypropane, PPTS, to provide the desired chiral benzyl ether fragment I. 




The synthesis of the fragment II (Scheme 14) began from the commercially available aldehyde 45 by subjecting it to a Wittig reaction using ethyl (triphenylphosphoranylidene) acetate to give an ,-unsaturated ester 57, which was reduced using DIBAL-H to give the corresponding allylic alcohol 58 in 92% yield.
  




Scheme 14. Reagents and conditions: a) Ph3P=CHCOOEt, benzene, rt, 1 h, 95%; b) Dibal-H, CH2Cl2, -15 oC– rt, 2 h, 92%; c) 4 Å MS, Ti(OiPr)4, (+)-DET, tBuOOH, CH2Cl2, -20 ºC, 10 h, 92%; d) Ph3P, Imidazole, Iodine, CH3CN-Et2O, 0 oC, 1.5 h, 90%; e) i. Zn/EtOH, reflux, 2 h, 95%; f) Ac2O, Et3N, DMAP, CH2Cl2, 0 oC-rt, 96%.

The epoxidation on allylic alcohol was  achieved under Sharpless conditions using (+)-DET to give chiral epoxy alcohol 59, which was converted to the corresponding epoxy iodide 60 using I2, TPP, imidazole in CH3CN-Et2O in isolated 90% yield. The iodo compound on refluxing in EtOH with zinc yielded the allylic alcohol 61, from which the corresponding allylic acetate II was prepared by treatment with Ac2O in presence of Et3N and DMAP to facilitate cross-metathesis reaction as shown in Scheme 14. After several trial reactions on cross-metathesis reaction between two fragments with different protecting groups we succeeded in getting high yields using allylic alcohol derivatives I and II as shown in Scheme 15. 
Accordingly, the chiral alcohol benzyl ether I was subjected to a cross-metathesis reaction with the allylic acetate II in the presence of Grubbs’ 2nd generation catalyst in refluxing DCM to furnish the desired cross-coupled product 62 (78%, based on conversion of I) along with the trace amounts of homodimerized product which was detected by MS. After hydrolysis of acetate group, the secondary hydroxyl group was protected as a TBDPS ether 64, followed by catalytic hydrogenation using Pd/C in EtOAc gave the primary alcohol 65 in 95% yield. 


 














Scheme 15. Reagents and conditions: a) 4 mol% Grubbs II catalyst, CH2Cl2, 40 °C, 10 h, 78%; b)  K2CO3, MeOH, r.t., 1 h, 95%; c) TBDPS-Cl, imidazole, dry CH2Cl2, 4h, 90%; d) Pd/C, H2, EtOAc, rt, 95%; e) i. Dess–Martin Periodinane, CH2Cl2, rt, 1 h; ii. allyl bromide, Zn, THF, 0 ºC – rt, 4 h, 88%; iii. Dess–Martin Periodinane, CH2Cl2, rt, 1.5 h, 85%; f) LiAlH4, LiI (1:1), Et2O, -100 0C-0 oC, 1 h, 86%; g) acryloyl chloride, Et3N, CH2Cl2, 0 ºC - rt, 1 h, 92%; h) Grubbs II catalyst, CH2Cl2, reflux, 40 °C, 3 h, 75%; i) HCl (5N), THF, rt, 8 h, 92%.

Oxidation of the resulting alcohol 65 with Dess-Martin periodinane in CH2Cl2 afforded the aldehyde, which on further treatment with allyl bromide and zinc in THF gave carbinol as a diastereomeric mixture which without characterization subjected to oxidation to give ketone 66, which was further subjected to a syn-stereoselective 1,3-asymmetric reduction using LiAlH4-LiI15 in ether at -100 oC to provide the desired homoallylic alcohol 67 in 86% yield (syn:anti = 95:5). The homoallylic alcohol 67 was esterified with acryloyl chloride to provide the diene 43. The RCM reaction in refluxing CH2Cl2 using Grubbs’ 2nd generation catalyst furnished the lactone 68, which on treatment with 5 N HCl in THF yielded the target molecule, passifloricin A 42 in 92% yield. The spectral data and optical rotation values are in agreement with those reported for the natural product.
In conclusion, the total synthesis of passifloricin A has been achieved in a stereocontrolled manner by the creation of chiral centers via Prins cyclisation, LAH/LiI and Sharpless asymmetric epoxidation reactions. 



SECTION B: Introduction: Total synthesis of (+)-Cryptocarya Diacetate. 
1,3-Polyol structural unit is common motif in many natural products. Cryptocarya diacetate 69 is simplest example of such natural products. It is an α,β-unsaturated lactone isolated by Drewes et al1 in 1995 from the leaves and bark of the South African plant Cryptocarya latifolia which has been long sought after for its legendary magical and medicinal properties.2 These properties range from the treatment of headaches and morning sickness to that of cancer, pulmonary diseases, various bacterial and fungal infections. The structure of cryptocarya diacetate was established by using spectral techniques COSY, HECTOR, DQFCOSY, HSQC and HMBC in order to give an unambiguous result. Using above techniques the 1H/1H correlations and all relevant 1H/13C correlations were made. 





Our ongoing project on synthesizing bioactive natural lactones,9 prompted us to explore the simple strategies for the synthesis of cryptocarya diacetate 69 as shown in a retrosynthetic plan (Scheme 16). 












Scheme 16.  Retrosynthetic plan

Accordingly, Cu mediated opening of the epoxide, (S)-benzyl glysidyl ether 1311 with vinyl magnesium bromide in THF afforded homoallylic alcohol 27, which on treatment with lithium in liquid NH3 underwent debenzylation to produce diol 28 (Scheme 17).














Scheme 17. reagents and conditions: a) Vinyl MgBr, CuCN, -78 oC- 40 oC, 4 h, 92%; b) Li, Liq. NH3, THF, -30 oC, 20 min, 75%; c) 3-(benzyloxy)propanal, TFA, CH2Cl2, K2CO3, MeOH, rt, 0.5 h, 65%; d) Et3N, TsCl, CH2Cl2, 0 oC-rt, 3 h, 95%; e) t-BuMe2SiCl, Imidazole, DMAP (cat.), CH2Cl2, rt, 92%; f) NaI, acetone, reflux, 24 h, 95%; g) Unactivated Zn, EtOH, reflux, 1h, 93%; h) p​-NO2CH2COOH, DEAD, Ph3P, THF, 0 oC-rt, 30 min, then K2CO3, MeOH, rt, 4 h 72%; i) TBAF, THF, 0 oC-rt, 4 h, 90%; j)acetonedimethylacetal, TsOH, DMSO, 2 h, 94%; k) PdCl2, Cu(OAc)2. H2O, O2, DMF:H2O (7:1) rt, 3-4 h, 77%; l) LiAlH4, LiI (1:1), Et2O  -100 oC-rt, 1 h, 84%; m) Ac2O, pyridine, DMAP (cat.), CH2Cl2, rt, 94%; n) Pd/C, H2, EtOAc, rt, 95%; o)i. Dessmartin periodonane, DCM, 0 oC; ii. (CF3CH2O)2 P(O)CH2COOCH3, NaH, THF, -80 oC, 0.5 h, 78%; p) (i) 0.1N HCl,  MeOH, 86% (ii) ZnCl2, THF, , 80% (iii) Ac2O, pyridine, CH2Cl2, DMAP (cat.), rt, 85% over three steps.

Prins cyclisation of 28 with 3-(benzyloxy)propanal in the presence of TFA followed by hydrolysis of the resulting trifluoroacetate yielded the desired trisubstituted pyran 12. Tosylation of 12 with 1.1 eq of tosyl chloride in the presence of Et3N in CH2Cl2 produced primary tosylate 32 in 95% yield. Silyl protection of 2o alcohol with t-BuMe2SiCl and imidazole in presence of catalytic amount of DMAP afforded the compound 73 in 92% yield. Compound 73 on exposure to NaI in refluxing acetone converted into the corresponding iodide 74 in 24 hr. The iodo compound 74 on exposure to unactivated Zn in refluxing EtOH furnished open chain key intermediate 72 with the anti 1,3-diol system. To get the 1,3-diol with required syn configuration, the hydroxyl group of 72 needs to be inverted. This reaction was performed by exposure of 72 to standard Mitsunobu conditions12 (DEAD, TPP and 4-nitro benzoic acid in dry THF followed by hydrolysis of the resultant ester with K2CO3 in MeOH) to procure the inverted alcohol 75 in 72% yield. Desilylation of 75 with TBAF gave 1,3 diol which was converted to acetonide 76 under conventional reaction conditions using 2,2-DMP in DMSO catalyzed by TsOH. The syn diol 76 was further confirmed13 by 13C NMR spectroscopy in accordance with the Recknovsky anology. The Compound 76 was transformed into the methyl ketone 71 under modified Wacker oxidation14 conditions using 0.1 eq of PdCl2, 0.2 of eq Cu(OAc)2.H2O in AcNMe2:H2O (7:1) in 77% yield. Keto compound 71 was subjected to syn-stereoselective reduction using 3 eq of LiAlH4, 3 eq of LiI9a in ether at -100 0C to provide the desired syn compound 77 in 84% yield (syn:anti selectivity 95:5). The secondary hydroxyl group was acetylated (Ac2O/ pyridine/CH2Cl2/rt), followed by the removal of benzyl protecting group (Pd-C/H2/EtOAc/rt) to get alcohol 70 in 95% yield. The alcohol 70 was then oxidized to the corresponding aldehyde in 88% using Dess–Martin periodinane in CH2Cl2. For the synthesis of the δ-lactone, the connecting moiety was a two-carbon unit with (Z)-configuration. This was achieved by a modified Wadsworth-Emmons reaction using methyl-(bistrifluoroethyl)-phosphonoacetate in the presence of NaH in THF to obtain exclusively the unsaturated (Z)-configurated ester 79. After hydrolyzing the acetonide with dilute acid, the lactonization of the hydroxy ester was achieved by treating with ZnCl2 in THF at reflux to give a hydroxylactone. Finally the hydroxyl group was acetylated using Ac2O/Pyridine/CH2Cl2/rt to provide the target molecule 69.
In conclusion, Prins cyclisation and LiI assested syn induction reactions were used for installing the chiral centers of the 1,3-polyol system of (+)-cryptocarya diacetate to accomplish its stereoselective synthesis.

CHAPTER III: Total Synthesis of (+)-Davanone, (+)-Nordavanone and  (+)-Davana Acid.

The novel sesquiterpenoids1 such as davana acid 80, nordavanone 81, and davanone 82 isolated from davana oil of Artemisia pallens, a plant grown in south India. Davanone 82 was also found in another plant Tanacetum Vulgare.2 The structures of these compounds were assigned on the basis of spectroscopic and degradative evidence.1c,3 In view of the importance of davana oil in the perfume industry, A. pallens is under commercial cultivation in India. The European countries, USA and Japan have shown tremendous interest in the oil, mainly for use in the flavouring of cakes, tobacco and in some costly beverages.4 Therefore, the interest has aroused in the chemical composition of the davana oil of Artemisia pallens and has been investigated by a number of research groups.5    


        



(+)-Davanone 82 is the principle component of davana oil and exhibits antifungal6 and antispasmodic activities.7 Inspite of their importance in perfume industry, a few reports8 mainly racemic syntheses9 appeared for the preparation of 80, 81 and 82. Recent synthesis of (+)-davanone10 also reports the isolation of 4 diastereomeric davana acid ethyl esters as intermediates.  Therefore, we undertook the stereospecific synthesis of these natural products and the results are reported here.



	









Scheme 18. Retrosynthesis

A retrosynthesis is depicted in Scheme 18. Compounds 80, 81 and 82 could be obtained from a key intermediate 83, which in turn could be realized from the aldehyde 84 by Evans syn aldol and cyclic ether formation. Aldehyde 84 could be made from (-)-linalool 85. The synthesis began with the commercially available (-)-linalool 85. Accordingly, (-)-linalool 85 was converted to its MOM ether 86 using MOM-Cl, and Hunig’s base in DCM (Scheme 19). Next, a two step sequence, comprising chemoselective dihydroxylation of the more electron rich C-C double bond (OsO4, K3Fe(CN)6, K2CO3, MeSO2NH2, t BuOH, H2O) in compound 86 and vicinal diol cleavage (NaIO4, H2O, Me2CO) furnished the required aldehyde 84 in good yield.
The aldehyde 84 was subjected to the Evans syn aldol12 reaction with the enolate of chiral N-propionyl oxazolidinone 87 to furnish the aldol adduct 88 in high yield and with high diastereoselactivity (87%, de 98%). Subsequent mesylation of the secondary hydroxyl (MsCl, Et3N, 96%) afforded hydroxyl mesylate 89 followed by MOM deprotection (HCl, THF, 90%) to give hydroxyl mesylate 90,  which on treatment with 2,6-lutidine at 120 oC quickly led to the formation of the cyclic ether in 93% yield as a single isomer anti,cis-83 SN2-type substitution (Scheme 19).















Scheme 19. Reagents and conditions: a) Hunig’s base, MOM-Cl, CH2Cl2, 0 oC- r. t., 1h, 88%; b) OsO4, K3Fe(CN)6, K2CO3, MeSO2NH2, t BuOH, H2O; c) NaIO4, H2O, Me2CO, 80% (over 2 steps); d) Bu2OTf, Et3N, CH2Cl2, -78 oC, 87%; e) MsCl, Et3N, 0 oC, 0.5h, 96%; f) HCl, THF, r. t., 1h, 90%; g) 2,6-Lutidine, 120 oC, 1h, 93%; h) H2O2, LiOH, H2O-THF, 82%; i) Dibal-H, CH2Cl2, -78 oC, 88%;  j) MeMgI, Et2O, 0 oC, 85%. l) C5H9ZnBr, HMPA, THF, reflux, 78%; k) IBX, DMSO, CH2Cl2, 2h, 0 oC- r. t.

Hydrolysis of 83 with LiOH, H2O2 in THF-H2O (1:1) afforded, after an acidic workup, the target davana acid 80 in 82% yield. However, cleavage of oxazolidinone in 83 using DIBAL-H provided aldehyde 91 in 88% yield, which was used immediately for the next reaction. The Grignard reaction of aldehyde 91 with methylmagnesium iodide provided a secondary alcohol 92 as a diastereomeric mixture in a ratio of 1:1, which without further characterization used for the next step. Oxidation of alcohol 92 using IBX in DMSO provided (+)-nordavanone 81 in 82% yield. Whereas, prenylation13 of aldehyde 91 with prenylzinc bromide in the presence of HMPA in THF furnished secondary alcohol 93 as a diastereomer (1:1) mixture in 78% yield. The alcohol 93 was oxidized using IBX to yield (+)-davanone 82 in 80% yield. The synthetic material proved to be identical with the reported .10
In summary, a concise asymmetric total synthesis of (+)-davana acid, (+)-nordavanone, and (+)-davanone has been accomplished using Evans syn aldol reaction and stereospecific cyclic ether formation as key steps.
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